首页> European journal of cancer (Oxford, England : 1990)> Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma.

Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ishan,Mehta

第一单位： Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

作者： Ishan,Mehta ^[1] ; Alimu,Dayimu ^[2] ; Satish,Kumar ^[3] ; Clare,Boobier ^[3] ; Olabode,Oladipo ^[4] ; David,Burke ^[4] ; Anna,Olson-Brown ^[5] ; Pembe,Yesildag ^[5] ; Jenny,Nobes ^[6] ; Stephanie,Brown ^[6] ; Catherine,Booth ^[1] ; Matthew,Wheater ^[7] ; Daniel,Muller ^[7] ; Vanessa,Fountain ^[8] ; Lucy,Ford ^[8] ; Ruth,Board ^[9] ; Luke,McGurk ^[9] ; Sophie,Twelves ^[10] ; Nikos,Demiris ^[10] ; Pippa,Corrie ^[11]

作者单位： Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. ^[1] Cambridge Clinical Trials Unit-Cancer Theme, University of Cambridge, Cambridge, UK. ^[2] Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, UK. ^[3] Cancer Centre, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, UK. ^[4] Clatterbridge Cancer Centre, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. ^[5] Norfolk & Norwich University Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK. ^[6] Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK. ^[7] Musgrove Park Hospital, Somerset NHS Foundation Trust, Taunton, UK. ^[8] Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK. ^[9] Cambridge Clinical Trials Unit-Cancer Theme, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. ^[10] Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Electronic address: philippa.corrie@nhs.net. ^[11]

关键词 Efficacy Melanoma Pembrolizumab Real-world data Scheduling Toxicity

医学主题词人类(Humans);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome);黑色素瘤(Melanoma)

DOI 10.1016/j.ejca.2023.113344

PMID 37804771

发布时间 2023-12-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交